Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/331030
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

A quality by design approach for the synthesis of palmitoyl-L-carnitine-loaded nanoemulsions as drug delivery systems

AutorArroyo-Urea, Eva María CSIC ORCID; Muñoz-Hernando, María; Leo-Barriga, Marta CSIC; Herranz, Fernando CSIC ORCID CVN; González-Paredes, Ana CSIC ORCID
Palabras claveNanoemulsion
drug delivery
design of experiments
colloidal stability
biodistribution
Fecha de publicación2023
EditorTaylor & Francis
CitaciónDrug Delivery: Journal of Delivery and Targeting of Therapeutic Agents 30 (1): 2023
ResumenNanoemulsions (NE) are lipid nanocarriers that can efficiently load hydrophobic active compounds, like palmitoyl-L-carnitine (pC), used here as model molecule. The use of design of experiments (DoE) approach is a useful tool to develop NEs with optimized properties, requiring less experiments compared to trial-and-error approach. In this work, NE were prepared by the solvent injection technique and DoE using a two-level fractional factorial design (FFD) as model was implemented for designing pC-loaded NE. NEs were fully characterized by a combination of techniques, studying its stability, scalability, pC entrapment and loading capacity and biodistribution, which was studied ex-vivo after injection of fluorescent NEs in mice. We selected the optimal composition for NE, named pC-NE, after analysis of four variables using DoE. pC-NE incorporated pC in a very efficient manner, with high entrapment efficiency (EE) and loading capacity. pC-NE did not change its initial colloidal properties stored at 4 °C in water during 120 days, nor in buffers with different pH values (5.3 and 7.4) during 30 days. Moreover, the scalability process did not affect NE properties and stability profile. Finally, biodistribution study showed that pC-NE formulation was predominantly concentrated in the liver, with minimal accumulation in spleen, stomach, and kidneys.
Versión del editorhttp://dx.doi.org/10.1080/10717544.2023.2179128
URIhttp://hdl.handle.net/10261/331030
DOI10.1080/10717544.2023.2179128
Identificadoresdoi: 10.1080/10717544.2023.2179128
issn: 1521-0464
Aparece en las colecciones: (IQM) Artículos




Mostrar el registro completo

CORE Recommender

SCOPUSTM   
Citations

4
checked on 24-abr-2024

WEB OF SCIENCETM
Citations

1
checked on 27-feb-2024

Page view(s)

24
checked on 27-abr-2024

Download(s)

38
checked on 27-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Este item está licenciado bajo una Licencia Creative Commons Creative Commons